Medical Director Appointed at Memorial Sloan Kettering’s Locations in Westchester, New Jersey, and Long Island
Ephraim Casper, MD, has been appointed Medical Director for the Memorial Sloan Kettering Regional Care Network, comprised of six outpatient suburban locations — three on Long Island; two in Westchester County, New York; and one in Basking Ridge,...
31-Jul-2014 2:00 PM EDT
Babies who are born with severe combined immunodeficiency (SCID) can be successfully treated with a transplant of blood-forming stem cells, according to experts led by Memorial Sloan Kettering’s Richard J. O’Reilly, MD.
28-Jul-2014 12:00 PM EDT
Memorial Sloan Kettering Cancer Center is proud and honored to announce it has been named the number one hospital for cancer care in the nation, according to U.S. News & World Report in its annual listing of Best Hospitals.
15-Jul-2014 8:00 AM EDT
Memorial Sloan Kettering Cancer Center (MSK) is partnering with DigitasLBi and Phase2 to help expand MSK’s digital reach.
20-Jun-2014 10:00 AM EDT
Memorial Sloan Kettering Cancer Center and Quest Diagnostics Partner to Advance Precision Medicine in Cancer Diagnosis and Treatment
Memorial Sloan Kettering Cancer Center and Quest Diagnostics announced a joint collaboration that will utilize MSK’s clinical and research insights into gene mutations associated with solid tumors. The goal is to use molecular laboratory testing...
1-Jun-2014 9:00 AM EDT
Study Using Comprehensive Genomic Tumor Testing to Match Lung Cancer Patients with Targeted Therapies Transforms Care
New data from a study led by Memorial Sloan Kettering physicians that used targeted therapy for patients with the most common type of lung cancer has helped transform treatment for the disease.
16-May-2014 2:00 PM EDT
Landmark Gift of $100 Million from the Marie-Josée and Henry R. Kravis Foundation Will Support Groundbreaking Approach to Precision Oncology
Memorial Sloan Kettering Cancer Center launched the Marie-Josée and Henry R. Kravis Center for Molecular Oncology, an ambitious initiative to improve cancer care and research through genomic analysis.
20-May-2014 8:00 AM EDT
Phase I Data Suggest PLX3397 Is a Potential Therapy for Patients with Advanced Pigmented Villonodular Synovitis
New research from Memorial Sloan Kettering highlighted in advance of the 50th Annual Meeting of the American Society of Clinical Oncology demonstrates the powerful clinical benefit of giving patients a drug that targets the molecular abnormality...
14-May-2014 5:00 PM EDT
9-Dec-2013 9:05 AM EST
3-Dec-2013 3:15 PM EST
20-Sep-2013 2:00 PM EDT
12-Mar-2013 6:00 PM EDT
28-Sep-2012 12:40 PM EDT